Literature DB >> 20417602

A functional requirement for PAK1 binding to the KH(2) domain of the fragile X protein-related FXR1.

Evonne Say1, Hwee-Goon Tay, Zhuo-shen Zhao, Yohendran Baskaran, Rong Li, Louis Lim, Ed Manser.   

Abstract

Loss of fragile X mental retardation protein FMR1 is the most common genetic cause of mental deficiency in man. We find that both FMR1 and the related FXR1 serve as direct binding partners for the Cdc42 effector PAK1. This involves an 11 residue segment in the PAK1 autoinhibitory domain that is exposed upon kinase activation and binds the FXR1 KH2 domain. Active PAK1 can phosphorylate FXR1 at Ser420; antibodies to this site show increased phosphorylation when fragile X proteins are recruited to stress granules. During zebrafish muscle development, FXR1 Ser420 phosphorylation is needed for protein function. The familial FMR1(I304N) mutation is biologically inactive, and FXR1(I304N) fails to bind PAK1. A different PAK1 binding-deficient mutant, FXR1(Q348K/E352A), fails to rescue loss of Zf-FXR1 unless combined with a gain-of-function S420D phosphomimetic. This is the first documented protein partner for the KH(2) domain of FMR1 or FXR1, and it has several implications for signaling by fragile X proteins. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20417602     DOI: 10.1016/j.molcel.2010.04.004

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  24 in total

Review 1.  PAK signalling during the development and progression of cancer.

Authors:  Maria Radu; Galina Semenova; Rachelle Kosoff; Jonathan Chernoff
Journal:  Nat Rev Cancer       Date:  2014-01       Impact factor: 60.716

2.  Augmented noncanonical BMP type II receptor signaling mediates the synaptic abnormality of fragile X syndrome.

Authors:  Risa Kashima; Sougata Roy; Manuel Ascano; Veronica Martinez-Cerdeno; Jeanelle Ariza-Torres; Sunghwan Kim; Justin Louie; Yao Lu; Patricio Leyton; Kenneth D Bloch; Thomas B Kornberg; Paul J Hagerman; Randi Hagerman; Giorgio Lagna; Akiko Hata
Journal:  Sci Signal       Date:  2016-06-07       Impact factor: 8.192

3.  Ezrin Binds to DEAD-Box RNA Helicase DDX3 and Regulates Its Function and Protein Level.

Authors:  Haydar Çelik; Kamal P Sajwan; Saravana P Selvanathan; Benjamin J Marsh; Amrita V Pai; Yasemin Saygideger Kont; Jenny Han; Tsion Z Minas; Said Rahim; Hayriye Verda Erkizan; Jeffrey A Toretsky; Aykut Üren
Journal:  Mol Cell Biol       Date:  2015-07-06       Impact factor: 4.272

Review 4.  MicroRNAs: Meta-controllers of gene expression in synaptic activity emerge as genetic and diagnostic markers of human disease.

Authors:  Stephanie Ceman; Julie Saugstad
Journal:  Pharmacol Ther       Date:  2011-01-20       Impact factor: 12.310

5.  Posttranscriptional activation of gene expression in Xenopus laevis oocytes by microRNA-protein complexes (microRNPs).

Authors:  Richard D Mortensen; Maria Serra; Joan A Steitz; Shobha Vasudevan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-02       Impact factor: 11.205

Review 6.  Fragile hearts: new insights into translational control in cardiac muscle.

Authors:  Daniela C Zarnescu; Carol C Gregorio
Journal:  Trends Cardiovasc Med       Date:  2013-04-10       Impact factor: 6.677

7.  p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.

Authors:  Hoi Yee Chow; Dina Stepanova; Jennifer Koch; Jonathan Chernoff
Journal:  PLoS One       Date:  2010-11-02       Impact factor: 3.240

8.  Do PAKs make good drug targets?

Authors:  Zhuo-Shen Zhao; Ed Manser
Journal:  F1000 Biol Rep       Date:  2010-09-23

9.  The Rac GTPase effector p21-activated kinase is essential for hematopoietic stem/progenitor cell migration and engraftment.

Authors:  Adrienne M Dorrance; Serena De Vita; Maria Radu; Pavankumar N G Reddy; Meaghan K McGuinness; Chad E Harris; Ronald Mathieu; Steven W Lane; Rachelle Kosoff; Michael D Milsom; Jonathan Chernoff; David A Williams
Journal:  Blood       Date:  2013-01-18       Impact factor: 22.113

Review 10.  Fragile X-related protein family: a double-edged sword in neurodevelopmental disorders and cancer.

Authors:  Mrinmoyee Majumder; Roger H Johnson; Viswanathan Palanisamy
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-09-02       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.